Campbell's (NASDAQ:CPB) Price Target Raised to $22.00 at JPMorgan Chase & Co.

Key Points

• JPMorgan raised Campbell’s price target from $20 to $22 but maintained a “neutral” rating, implying 4.34% downside from the stock’s previous close.
• Analyst sentiment remains cautious: Campbell’s has an average “Reduce” rating and a consensus price target of $20.47, with 12 Hold and seven Sell ratings.
• Campbell’s last quarter exceeded earnings expectations, reporting $0.50 EPS versus $0.48 expected, though revenue fell 4.4% year over year to $2.37 billion.

Campbell's (NASDAQ:CPB - Get Free Report) had its price objective boosted by equities research analysts at JPMorgan Chase & Co. from $20.00 to $22.00 in a research report issued on Tuesday,Benzinga reports. The brokerage presently has a "neutral" rating on the stock. JPMorgan Chase & Co.'s target price would indicate a potential downside of 4.34% from the stock's previous close.

Several other analysts have also recently commented on the company. Royal Bank Of Canada reduced their price target on Campbell's from $23.00 to $21.00 and set a "sector perform" rating for the company in a report on Tuesday, June 9th. DA Davidson raised Campbell's to a "hold" rating in a report on Monday, July 6th. Bank of America reduced their target price on Campbell's from $20.00 to $18.00 and set an "underperform" rating for the company in a report on Tuesday, June 9th. Barclays decreased their target price on shares of Campbell's from $21.00 to $19.00 and set an "underweight" rating on the stock in a research report on Monday, June 8th. Finally, UBS Group cut their price target on shares of Campbell's from $19.00 to $17.00 and set a "sell" rating for the company in a report on Tuesday, June 9th. Twelve investment analysts have rated the stock with a Hold rating and seven have assigned a Sell rating to the stock. Based on data from MarketBeat.com, the stock currently has an average rating of "Reduce" and an average price target of $20.47.

Campbell's Stock Performance

Campbell's stock traded up $0.32 during mid-day trading on Tuesday, reaching $23.00. 644,648 shares of the company were exchanged, compared to its average volume of 8,209,148. The firm's 50-day simple moving average is $22.34 and its two-hundred day simple moving average is $22.80. Campbell's has a twelve month low of $19.56 and a twelve month high of $34.17. The firm has a market cap of $6.86 billion, a PE ratio of 11.36 and a beta of 0.02. The company has a debt-to-equity ratio of 1.53, a quick ratio of 0.38 and a current ratio of 0.87.

Campbell's (NASDAQ:CPB - Get Free Report) last issued its earnings results on Monday, June 8th. The company reported $0.50 earnings per share for the quarter, beating the consensus estimate of $0.48 by $0.02. Campbell's had a net margin of 6.12% and a return on equity of 18.04%. The business had revenue of $2.37 billion for the quarter. During the same period in the previous year, the firm earned $0.22 EPS. The firm's revenue was down 4.4% on a year-over-year basis. Campbell's has set its FY 2026 guidance at 2.150-2.250 EPS. Equities analysts predict that Campbell's will post 2.18 earnings per share for the current fiscal year.

Institutional Trading of Campbell's

A number of large investors have recently made changes to their positions in the stock. Los Angeles Capital Management LLC purchased a new stake in shares of Campbell's in the fourth quarter valued at $29,000. Geneos Wealth Management Inc. boosted its stake in Campbell's by 333.3% in the 1st quarter. Geneos Wealth Management Inc. now owns 975 shares of the company's stock worth $39,000 after buying an additional 750 shares during the last quarter. Sittner & Nelson LLC purchased a new stake in Campbell's in the 4th quarter valued at about $29,000. Ankerstar Wealth LLC purchased a new stake in Campbell's in the 4th quarter valued at about $29,000. Finally, IFP Advisors Inc acquired a new position in shares of Campbell's during the 3rd quarter valued at about $37,000. Institutional investors and hedge funds own 52.35% of the company's stock.

About Campbell's

Campbell's NASDAQ: CPB is a leading manufacturer of shelf-stable foods and beverages, best known for its iconic soups and broths. Headquartered in Camden, New Jersey, the company offers a diverse portfolio of products designed to meet consumer demand for convenient, affordable meals and snacks. Since its founding in 1869, Campbell's has grown through a combination of organic innovation and strategic acquisitions to expand its presence in the food industry.

The company's brand portfolio includes Campbell's Condensed Soups, V8 juices, Prego pasta sauces, Swanson broths and stocks, Pace salsas and dips, and Pepperidge Farm baked snacks.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source